Palmitoylethanolamide

Palmitoylethanolamide

Best for

Ease neuropathy symptoms

Large effect, needs confirmation 400–1200 mg/day 4–12 weeks 5 studies, n=221 #1 of 12 studied

Palmitoylethanolamide provides a proven benefit for persistent pain in adults, with the strongest evidence showing more pain-free time; evidence across other outcomes is less established.

Median effective dose, most-studied outcomes

  • Feel less intense pain 1,050 mg 4–12 wk
  • Ease neuropathic pain 1,200 mg 4–8 wk
  • Ease neuropathy symptoms 600 mg 8 wk
Full protocol, 4 outcomes

Risk, worst reported severity

  • fatigue (severe episode) severe
  • palpitations moderate
  • morphine moderate
  • acetaminophen moderate
All 16 events and interactions

What palmitoylethanolamide actually does

Outcome Effect Evidence Dose Time Rank
Clear benefits 1
Feel less pain Proven benefit Pain relief can make it easier to move, rest, focus, and get through the day.
moderate
2 meta-analyses 4 papers · n=1.4k 300–1800 mg 4–12 wk #4 /50
Worth watching 3
Ease neuropathy symptoms Large effect, needs confirmation Neuropathy can cause pain, numbness, tingling, weakness, and changes in sensation.
large
5 RCTs 5 papers · n=221 400–1200 mg 4–12 wk #1 /12
Lower systemic inflammation Large effect, needs confirmation The immune system can drive body-wide inflammation that affects long-term health and how people feel day to day.
large
3 RCTs 3 papers · n=202 150–600 mg 0–8 wk
Ease neuropathic pain Promising early signal Neuropathic pain comes from damaged or irritated nerves and can feel burning, shooting, or electric.
moderate
2 RCTs 2 papers · n=94 600–1200 mg 4–8 wk #1 /5

Effect tiers come from native-unit MCID where available, Cohen's d otherwise.

Protocol

Dose, timing & forms

How much

For general pain, trials span 300 to 1,800 mg daily, with many protocols landing near 1,200 mg daily and running for roughly 4 to 12 weeks. 1 Nerve-pain studies most often use 600 to 1,200 mg daily, while early neuropathy studies also include lower daily intakes around 400 to 800 mg. 2 Start with the product label and do not chase the highest study dose without clinician input, particularly if you use pain medicine.

When and how long

PEA works as a daily routine, not as a fast, take-it-only-when-it-hurts option. Studies generally evaluate steady oral use over weeks, so pick a time you can repeat every day. 1 2 If your daily serving is split on the label, dividing it across morning and evening can make the habit easier to sustain. Trial reports do not establish one universally superior time of day or a required relationship to meals. 1 2

Forms & standardisation

Look for oral PEA that clearly lists the amount of palmitoylethanolamide per serving. Micronized and ultramicronized PEA are common forms designed to make this poorly water-soluble fat-like compound easier for the body to absorb, and these forms feature prominently in pain research. 1 2 A sublingual product can include sorbitol, which has caused stomach upset or diarrhea in some users, so check the inactive ingredients as well.

Studied range, by outcome

Outcome Studied range Median effective Duration Evidence
Feel less intense pain 300–1,800 mg 1,050 mg 4–12 wk 4 papers 10 sig. endpoints
Ease neuropathic pain 600–1,200 mg 1,200 mg 4–8 wk 2 papers 9 sig. endpoints
Ease neuropathy symptoms 400–800 mg 600 mg 8 wk 2 papers 3 sig. endpoints
Support lower whole-body inflammation 600 mg 600 mg 8 wk 1 paper 1 sig. endpoint

Adverse events and drug interactions

Safety events

fatigue (severe episode) severe
palpitations moderate
urticaria moderate
drowsiness mild
gastrointestinal discomfort / diarrhea (sublingual formulation, sorbitol-associated) mild
diarrhea mild
dyspepsia mild
nausea mild

Drug interactions

morphine moderate increases effect
acetaminophen moderate increases effect
tramadol moderate increases effect
oxycodone moderate increases effect
paclitaxel moderate decreases effect
interferon beta moderate increases effect
citalopram minor additive
levodopa minor additive
Buy well

Recommended Palmitoylethanolamide products

Real products that dose Palmitoylethanolamide where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.

In context

What this is and how it works

  • Across 4 studies (n=1,399), palmitoylethanolamide increased time free from pain; effect size and MCID comparison were not reported 1.
  • The reviewed evidence spans 18 papers and 54 outcomes, with strongest support for chronic pain relief.
  • Neuropathic-pain benefits remain encouraging but rest on limited evidence from early studies 2.

Palmitoylethanolamide, usually shortened to PEA, is a fat-like molecule found naturally in your body and in small amounts in foods such as egg yolk and peanuts. It is not a cannabis product, even though it sits near some of the same pain-signaling biology. Researchers study supplemental PEA mainly for persistent pain and nerve-related discomfort. 3

PEA activates PPAR-alpha, a protein that acts like a thermostat for inflammatory signaling, turning down some of the chemical noise that keeps pain-sensing tissues on high alert. It also influences immune cells called mast cells and glial cells, which can amplify pain signals when they stay activated too long. 3

Bottom line

PEA is a reasonable option for an adult looking for additional support with persistent general pain, with moderate evidence that it reduces pain intensity. 1 Its nerve-pain results look encouraging, including some large early effects, but the evidence remains too limited for a sure thing. 2 Skip self-experimenting if you take prescription pain medicines or have had palpitations, hives, severe fatigue, or unusual drowsiness, and get clinician guidance first.

Frequently asked

Common questions

What is palmitoylethanolamide used for?

PEA has its clearest support for reducing general pain intensity. Early clinical findings also point to relief of burning, tingling, and other nerve-pain symptoms, but those results need stronger confirmation. 1 2

How long does palmitoylethanolamide take to work?

Pain trials commonly assessed outcomes after about 4 to 12 weeks of daily use. Give a consistent routine several weeks before deciding whether it changes your symptoms. 1 2

Is palmitoylethanolamide the same as CBD?

No. PEA is a fat-like compound that your body also makes, while CBD comes from cannabis. PEA influences some overlapping pain-signaling systems but primarily works through a cellular inflammation-control switch called PPAR-alpha. 3

Can you take palmitoylethanolamide with pain medicine?

Talk with a clinician or pharmacist first. PEA can increase the effects of several pain medicines, including opioid pain relievers and acetaminophen, so combining them deserves individual guidance.

Sources

Sources

  1. 1. Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis (2014)
  2. 2. Palmitoylethanolamide in the treatment of neuropathic pain associated with lumbosciatica (2009)
  3. 3. Palmitoylethanolamide in homeostatic and neuropathic pain: the role of PPAR-alpha (2014)

Generated August 27, 2026